Dr. Ofer Sharon

OncoHost

Proteomic analysis to predict response to immunotherapy

Watch this presentation by Dr. Ofer Sharon, CEO, OncoHost, titled: Proteomic analysis to predict response to immunotherapy. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.



LIKE 9
Dr. Ofer Sharon
Virtual summit Cancer Research

Dr. Ofer Sharon

Biography

Dr. Ofer Sharon received his... More
Follow Ofer

Dr. Ofer Sharon

OncoHost

Dr. Ofer Sharon received his M.D. from Tel Aviv University in 2000. With almost two decades of experience in the oncology drug development industry, Sharon is the CEO of OncoHost, a therapeutics company that develops personalized strategies to help maximize the success of cancer therapies by utilizing proprietary proteomic analysis.